These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2118543)

  • 1. Successful treatment of infertile women with hypothalamic primary and secondary protracted amenorrhoea using gonadotrophin releasing hormone analogue and human menopausal gonadotrophin.
    Aboulghar MA; Mansour RT; Serour GI; Ramzy AM
    Hum Reprod; 1990 Jul; 5(5):557-60. PubMed ID: 2118543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
    Aboulghar MA; Mansour RT; Serour GI
    Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
    Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
    J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized prospective study of gonadotrophin with or without gonadotrophin-releasing hormone agonist for treatment of unexplained infertility.
    Sengoku K; Tamate K; Takaoka Y; Morishita N; Ishikawa M
    Hum Reprod; 1994 Jun; 9(6):1043-7. PubMed ID: 7962373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.
    Homburg R; Eshel A; Kilborn J; Adams J; Jacobs HS
    Hum Reprod; 1990 Jan; 5(1):32-5. PubMed ID: 2108981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human prolactin release induced by follicle stimulating hormone, luteinizing hormone and human chorionic gonadotrophin.
    Crosignani PG; Maini MC; Negri E; Ragni G
    Hum Reprod; 1991 Sep; 6(8):1070-3. PubMed ID: 1806563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
    Armitage M; Wilkin T; Dewbury K
    Br Med J (Clin Res Ed); 1987 Jul; 295(6590):96. PubMed ID: 3113653
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women.
    Smitz J; Van Den Abbeel E; Bollen N; Camus M; Devroey P; Tournaye H; Van Steirteghem AC
    Hum Reprod; 1992 Sep; 7(8):1098-102. PubMed ID: 1400933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buserelin suppression of endogenous gonadotropin secretion in infertile women with ovarian feedback disorders given human menopausal/human chorionic gonadotropin treatment.
    Weise HC; Fiedler K; Kato K
    Fertil Steril; 1988 Mar; 49(3):399-403. PubMed ID: 3125067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ovulation in a thalassaemic patient.
    De Sanctis V; Vullo C; Negri P; Codemi L; Mollica G; Bagni B
    Acta Eur Fertil; 1989; 20(4):223-5. PubMed ID: 2519575
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins.
    Fleming R; Haxton MJ; Hamilton MP; McCune GS; Black WP; MacNaughton MC; Coutts JR
    Br J Obstet Gynaecol; 1985 Apr; 92(4):369-73. PubMed ID: 3921050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of polycystic ovarian disease by inducing ovulation with pulsatile subcutaneous administration of human menopausal gonadotrophin associated with luteinizing hormone-releasing hormone analogue.
    Nakamura Y; Yoshimura Y; Tamaoka Y; Ubukata Y; Yoshida K; Yamada H; Iizuka R; Suzuki M
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):395-402. PubMed ID: 3150824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG.
    Smitz J; Devroey P; Braeckmans P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1987 May; 2(4):309-14. PubMed ID: 3114314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone.
    Hughes SM; Huang ZH; Matson PL; Buck P; Lieberman BA; Morris ID
    Hum Reprod; 1992 Jul; 7(6):770-5. PubMed ID: 1500473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?
    Wada I; Matson PL; Horne G; Buck P; Lieberman BA
    Hum Reprod; 1992 Sep; 7(8):1090-3. PubMed ID: 1400932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
    Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
    Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new systematic treatment for infertile women with abnormal hormone profiles.
    Fleming R; Adam AH; Barlow DH; Black WP; MacNaughton MC; Coutts JR
    Br J Obstet Gynaecol; 1982 Jan; 89(1):80-3. PubMed ID: 6800399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu.
    Cassidenti DL; Paulson RJ; Lobo RA; Sauer MV
    Hum Reprod; 1992 Mar; 7(3):344-8. PubMed ID: 1587939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.